Exploring genetic and social factors in substance use disorders
Official title: Using novel data sources across genetic, biological, and social domains to refine genome-wide investigations of substance use disorders
Funded at Yale University · NIH-10985085 · Data updated 2026-11-12
This study is looking at how our genes and social factors can influence substance use problems, especially for people who might not have been diagnosed yet, to help find better ways to understand and support those dealing with these challenges.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $181,040 |
| NIH project number | 1K01DA058807-01A1 |
| Project ID | NIH-10985085 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with a history of substance use or those who have experienced substance use disorders.
✕Less likely to help
Patients who have never used substances or do not have any history of substance use disorders may not benefit from this research.
What this research studies
This research investigates the genetic and social influences on substance use disorders (SUDs) by utilizing advanced data sources. It aims to improve the understanding of how different substances interact and affect individuals, particularly focusing on those who may not have a formal diagnosis. By analyzing electronic health records and toxicology data, the research seeks to identify genetic predispositions and better define the characteristics of individuals affected by SUDs. This comprehensive approach could lead to more accurate diagnoses and targeted interventions for those struggling with substance use.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and personalized treatment strategies for individuals with substance use disorders.
How similar studies have gone: Previous research has shown promise in using genetic and electronic health record data to understand substance use disorders, indicating that this approach could yield valuable insights.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Deak, Joseph D. — Yale University
- Study coordinator: Deak, Joseph D.
Related research
Other NIH-funded projects on the same topics.
-
Improving contraception decisions for women with substance use disorders after childbirth
A patient-centered decision tool called MyPath aims to help postpartum women with substance use disorders choose and keep effective contraception after giving birth.
-
Transforming prison care for HIV, HIV risk, and substance use disorders
A patient-friendly look at improving HIV care and prevention for people in state prisons, especially where substance use is common.
-
Genetic factors behind alcohol and opioid use disorders and depression in veterans
A study using genetic data from veterans to understand how genes contribute to co-occurring alcohol use, prescription opioid use, and depression.
-
Written Exposure Therapy for Veterans with PTSD and Substance Use Disorder (brief trauma treatment)
A brief trauma-focused therapy called Written Exposure Therapy is being studied to help veterans who have both PTSD and substance use disorders.
-
Web-based training to treat PTSD and substance use together in Veterans
A web-based training resource helps VA clinicians learn how to provide integrated treatment for Veterans with both PTSD and substance use disorders.
-
Mobile health support to help Veterans with substance use disorders function better after treatment
A smartphone app, based on Motivational Enhancement Therapy, is being developed to help Veterans stay on track and function better after leaving residential substance use treatment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.